Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN Recorded on June 23, 2026 Stephen Ansell, MD, PhD Division Chair, Hematology Mayo Clinic Rochester, MN Join Dr. Stephen Ansell from Mayo Clinic for an in-depth discussion on Waldenström macroglobulinemia, focusing on the latest advances in diagnosis, treatment, and management. This episode explores clinical features, the importance of molecular markers in guiding diagnosis and treatment decisions, and current indications for initiating therapy. The discussion also addresses the management of IgM-related complications, emerging therapeutic approaches, and future directions in care. Listen to this exciting and informative episode today! Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Treating Blood Cancers
Mastocytosis: What Clinicians Need to Know
CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support
Optimizing HSCT in Blood Cancers
Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology Care
Get summaries like this every morning.
Free AI-powered recaps of Treating Blood Cancers and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.